p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia. / Pierce, Andrew; PJ, Owen-Lynch; E, Spooncer et al.
Yn: Oncogene, Cyfrol 17, 10.08.1998, t. 667-672.
Yn: Oncogene, Cyfrol 17, 10.08.1998, t. 667-672.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Pierce, A, PJ, O-L, E, S, TM, D & AD, W 1998, 'p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.', Oncogene, cyfrol. 17, tt. 667-672. https://doi.org/10.1038/sj.onc.1201969
APA
Pierce, A., PJ, O.-L., E, S., TM, D., & AD, W. (1998). p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia. Oncogene, 17, 667-672. https://doi.org/10.1038/sj.onc.1201969
CBE
Pierce A, PJ O-L, E S, TM D, AD W. 1998. p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia. Oncogene. 17:667-672. https://doi.org/10.1038/sj.onc.1201969
MLA
Pierce, Andrew et al. "p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.". Oncogene. 1998, 17. 667-672. https://doi.org/10.1038/sj.onc.1201969
VancouverVancouver
Pierce A, PJ OL, E S, TM D, AD W. p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia. Oncogene. 1998 Awst 10;17:667-672. doi: 10.1038/sj.onc.1201969
Author
RIS
TY - JOUR
T1 - p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.
AU - Pierce, Andrew
AU - PJ, Owen-Lynch
AU - E, Spooncer
AU - TM, Dexter
AU - AD, Whetton
PY - 1998/8/10
Y1 - 1998/8/10
U2 - 10.1038/sj.onc.1201969
DO - 10.1038/sj.onc.1201969
M3 - Article
VL - 17
SP - 667
EP - 672
JO - Oncogene
JF - Oncogene
SN - 0950-9232
ER -